Vericel to Present at the 5th Annual Cell & Gene Therapy Investor Day – Nasdaq
|
Vericel to Present at the 5th Annual Cell & Gene Therapy Investor Day
Nasdaq CAMBRIDGE, Mass., April 20, 2017 (GLOBE NEWSWIRE) — Vericel Corporation (Nasdaq:VCEL), a leading developer of expanded autologous cell therapies for the treatment of patients with serious diseases and conditions, today announced that Nick … Homology Medicines to Present at the Alliance for Regenerative Medicine's Cell & Gene Therapy Investor Day |
